Literature DB >> 12232459

Necrotizing sarcoid granulomatosis presenting with elevated serum soluble interleukin-2 receptor levels.

Toshiyuki Harada1, Toraji Amano, Ayumu Takahashi, Jungo Furuya, Etsuro Yamaguchi, Mitsuhito Kaji, Toshiaki Morikawa, Tomoo Itoh, Michio Shimizu, Masaharu Nishimura.   

Abstract

A 52-year-old woman presented with a one-week history of low-grade fever and dyspnea. A CT scan showed multiple pulmonary nodules with cavitation, as well as bilateral pleural thickenings with effusions. A specimen resected by video-assisted thoracoscopic surgery showed multiple confluent granulomas with central necrosis and granulomatous vasculitis. These findings were consistent with necrotizing sarcoid granulomatosis. An elevated serum soluble interleukin-2 receptor level became normal following clinical and radiological improvement. This indicates that the serum soluble interleukin-2 receptor can be a useful marker for the clinical management of necrotizing sarcoid granulomatosis. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12232459     DOI: 10.1159/000064013

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

Review 1.  Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.

Authors:  Bader Alenezi; Esther Lamoureux; Lesley Alpert; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Granulomatous Sarcoidosis Mimics.

Authors:  Marc A Judson
Journal:  Front Med (Lausanne)       Date:  2021-07-08

3.  Necrotizing Sarcoid Granulomatosis: Possibly Veiled Disease in Endemic Area of Mycobacterial Infection.

Authors:  Yosep Chong; Eun Jung Lee; Chang Suk Kang; Tae-Jung Kim; Jung Sup Song; Hyosup Shim
Journal:  J Pathol Transl Med       Date:  2015-07-15

Review 4.  Necrotizing sarcoid granulomatosis with hemoptysis: a case report and literature review.

Authors:  Haidong Huang; Chen Li; Chong Bai; Qiang Li; Weiqiang Zheng; Zhi Zhu; Paul Zarogoulidis; Konstantinos Zarogoulidis; Andreas Gschwendtner; Wolfgang Hohenforst-Schmidt; Michael Simoff
Journal:  Diagn Pathol       Date:  2013-05-13       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.